2019
DOI: 10.1016/j.ajps.2018.05.010
|View full text |Cite
|
Sign up to set email alerts
|

A method of elevated temperatures coupled with magnetic stirring to predict real time release from long acting progesterone PLGA microspheres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 42 publications
0
7
0
Order By: Relevance
“…Indeed, the release of the drug away from the release surfaces, the water or the medium, takes longer to migrate through the thickness of the polymer [2,35]. This study is applicable in all cases of drug delivery as stents, ear pads, patches, and contact lenses [6,34,[36][37][38][39][40][41]. In all these cases, some parameters have importance like the geometry of the drug holders, glass transition temperature, viscosity, drug percentage, drug type, coating thickness, and release kinetics [6,28].…”
Section: Introductionmentioning
confidence: 89%
See 1 more Smart Citation
“…Indeed, the release of the drug away from the release surfaces, the water or the medium, takes longer to migrate through the thickness of the polymer [2,35]. This study is applicable in all cases of drug delivery as stents, ear pads, patches, and contact lenses [6,34,[36][37][38][39][40][41]. In all these cases, some parameters have importance like the geometry of the drug holders, glass transition temperature, viscosity, drug percentage, drug type, coating thickness, and release kinetics [6,28].…”
Section: Introductionmentioning
confidence: 89%
“…However, in Ref. [34] Ye et al found that the increase in temperature significantly changed the drug release profile from PLGA progesterone microspheres, because of mechanism change. In the diffusion-controlled system, the drug is released through the pores, polymeric membranes and chains.…”
Section: Introductionmentioning
confidence: 99%
“…To monitor the amount of drug released from the microparticles, a sample for analysis is prepared by separating the supernatant from the precipitated microparticles after centrifugation. When the drug is stable in the release medium, the supernatant is periodically taken and the filtered samples are analyzed by spectrophotometric or chromatographic methods [ 32 , 33 ]. For drugs that are unstable in the release medium, residual microparticles are recovered and the drug remaining in the microparticles is analyzed to indirectly determine the amount of drug released [ 34 , 35 ].…”
Section: In Vitro Drug Release Testing Methodsmentioning
confidence: 99%
“…PLGA-based DDSs include morphologies such as microparticles or microspheres [ 40 ], nanofibers [ 41 ], films [ 42 ], foams [ 43 ], gels [ 44 ], nanoparticles [ 45 , 46 ], among others [ 30 , 35 ]. Being of a size that allows them to navigate freely through the body and remain for a long period of time in the blood circulatory system, nanoparticles, especially polymeric ones, have shown great potential as DDS [ 47 , 48 ].…”
Section: Introductionmentioning
confidence: 99%
“…The initial stage is due to the presence of non-encapsulated drug molecules on the surface, drug particles attached to the surface of the nanoparticle [ 61 ], diffusion of the active compound through the polymeric matrix, diffusion of the encapsulated agent through water-filled pores, penetration of the surrounding medium from the surface to the center of the nanoparticle and activation of the hydrolytic degradation of the PLGA [ 58 , 62 ]. Initial hydrolytic degradation of the polymer and diffusion of the drug through the polymer matrix are also present, although their impact is minor [ 30 , 40 , 58 ]. The hydrophilic or hydrophobic nature of the encapsulating agent and its molecular weight also play an important role in this phase [ 32 ].…”
Section: Introductionmentioning
confidence: 99%